Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
83.39
+0.95 (1.15%)
At close: Nov 7, 2025, 4:00 PM EST
84.00
+0.61 (0.73%)
After-hours: Nov 7, 2025, 7:46 PM EST
Edwards Lifesciences Market Cap
Edwards Lifesciences has a market cap or net worth of $48.39 billion as of November 7, 2025. Its market cap has increased by 13.84% in one year.
Market Cap
48.39B
Enterprise Value
45.24B
1-Year Change
13.84%
Ranking
Category
Stock Price
$83.39
Market Cap Chart
Since March 27, 2000, Edwards Lifesciences's market cap has increased from $958.50M to $48.39B, an increase of 4,948.64%. That is a compound annual growth rate of 16.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 48.37B | 10.77% |
| Dec 31, 2024 | 43.66B | -5.51% |
| Dec 29, 2023 | 46.21B | 0.17% |
| Dec 30, 2022 | 46.13B | -42.97% |
| Dec 31, 2021 | 80.88B | 42.25% |
| Dec 31, 2020 | 56.86B | 16.86% |
| Dec 31, 2019 | 48.66B | 51.96% |
| Dec 31, 2018 | 32.02B | 34.25% |
| Dec 29, 2017 | 23.85B | 19.05% |
| Dec 30, 2016 | 20.03B | 17.59% |
| Dec 31, 2015 | 17.04B | 25.03% |
| Dec 31, 2014 | 13.63B | 89.40% |
| Dec 31, 2013 | 7.19B | -30.86% |
| Dec 31, 2012 | 10.41B | 29.03% |
| Dec 30, 2011 | 8.06B | -12.62% |
| Dec 31, 2010 | 9.23B | 87.85% |
| Dec 31, 2009 | 4.91B | 60.64% |
| Dec 31, 2008 | 3.06B | 17.27% |
| Dec 31, 2007 | 2.61B | -4.23% |
| Dec 29, 2006 | 2.72B | 10.05% |
| Dec 30, 2005 | 2.47B | 0.91% |
| Dec 31, 2004 | 2.45B | 37.56% |
| Dec 31, 2003 | 1.78B | 16.52% |
| Dec 31, 2002 | 1.53B | -6.49% |
| Dec 31, 2001 | 1.64B | 57.15% |
View and export this data all the way back to 2000. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 839.37B |
| Johnson & Johnson | 450.47B |
| AbbVie | 387.13B |
| UnitedHealth Group | 291.28B |
| AstraZeneca | 260.82B |
| Novartis AG | 242.27B |
| Abbott Laboratories | 217.27B |
| Merck & Co. | 212.91B |